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In the title compound, C27H22Cl3N3O2, the dihydropyridine
ring has a boat conformation. The molecules are linked by N—
H  O, N—H  Cl, C—H  N and C—H  O hydrogen
bonds.
Comment
1,4-Dihydropyridines are known for their pronounced drug
activity, such as calcium channel antagonists (Janis & Triggle,
1983) and antihypertensive agents (Fossheim et al., 1982).
Recently, symmetrical 1,4-dihydropyridines (1,4-DHP) having
3,5-dicarbamoyl substituents (Desai et al., 2001) opened up a
fresh approach to the synthesis of new molecules having better
pharmacokinetic properties (Triggle, 2003). Our group has
synthesized and studied antitubercular activity by applying
two- and three-dimensional quantitative structure–activity
relationships (QSAR) to a series of 3,5-dicarbamoyl func-
tionalities in 1,4-dihydropyridine (Desai et al., 2001; Kharkar
et al., 2002). It was assumed that the presence of a group such
as Cl or CH3 at position 2 of the substituted phenylcarbamoyl
group decreased the solvent-accessible surface area around
the amide bond and hence decreased the antitubercular
activity. However, when an electron-withdrawing group is
present at position 2 of the phenylcarbamoyl group it results in
higher activity (Kharkar et al., 2002). Against this background,
the title compound, (I) (Fig. 1), was synthesized and its crystal
structure is reported here.
Most of the bond lengths and angles have normal values
and are comparable with those reported for similar structures
(Sagar et al., 1999; Mahendra et al., 2004). The 1,4-DHP ring
has a boat conformation, with atoms N1 and C4 displaced by
0.126 (3) and 0.271 (3) A˚, respectively, from the mean plane
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through the other four C atoms. The other structural char-
acteristics are the conformations of the 2-chlorophenyl-
carbamoyl groups on the dihydropyridine ring. Each carbonyl
group of 2-chlorophenylcarbamoyl can be oriented in a
synperiplanar (cis) or antiperiplanar (trans) conformation
with respect to the adjacent C C double bond of the
dihdropyridine ring. The observed torsion angles are C2—
C3—C9—O10 [168.5 (3)] and C6—C5—C19—O20
[28.8 (5)], indicating trans and cis conformations, respectively.
The structure exhibits both intra- and intermolecular
hydrogen bonds (Table 2 and Fig. 2), which help to stabilize
the crystal structure. The intermolecular hydrogen bonds
N1—H1  O20i and C34—H34  O10ii (symmetry codes as in
Table 2) link the molecules into infinite one-dimensional
chains (Fig. 2).
Experimental
A mixture of 2-chloroacetoacetanilide (4.22 g, 0.02 mol) and
4-chlorobenzaldehyde (1.40 g, 0.01 mol) was heated continuously at
reflux for 15 min, with stirring, using 30 ml methanol as solvent.
Ammonia (4 ml) was added to the reaction mixture after 3 h. A light-
yellow product separated in the flask; this was filtered off, washed
twice with methanol and finally dried in a hot-air oven. Recrystalli-
zation from dimethylformamide gave a yield of 53–54% (m.p. 472 K).
Analysis calculated: C 64.37, H 4.82, Cl13.57, N 8.04, O 9.19%. 3 g was
taken up in 30 ml of methanol/dimethylformamide (8:2). Charcoal
(3 g) was added and the solution heated for 5 min. It was then filtered
while hot through a Whatman 42 filter paper. The solution was kept
for 30 d in a conical flask with the stopper left slightly open, and pale-
yellow crystals grew by evaporation.
Crystal data
C27H22Cl3N3O2
Mr = 526.83
Monoclinic, C2=c
a = 20.566 (2) A˚
b = 10.698 (1) A˚
c = 22.789 (2) A˚
 = 104.300 (2)
V = 4858.6 (6) A˚3
Z = 8
Dx = 1.440 Mg m
3
Mo K radiation
Cell parameters from 8244
reflections
 = 2.2–27.9
 = 0.41 mm1
T = 295 (2) K
Block, pale yellow
0.25  0.2  0.2 mm
Data collection
MacScience DIPLabo 32001
diffractometer
! scans
Absorption correction: none
8244 measured reflections
4452 independent reflections
3458 reflections with I > 2(I)
Rint = 0.017
max = 27.9

h = 23 ! 24
k = 10 ! 11
l = 29 ! 29
Refinement
Refinement on F 2
R[F 2 > 2(F 2)] = 0.051
wR(F 2) = 0.181
S = 1.06
4452 reflections
318 parameters
H-atom parameters constrained
w = 1/[2(Fo
2) + (0.0987P)2
+ 5.2071P]
where P = (Fo
2 + 2Fc
2)/3
(/)max = 0.001
max = 0.57 e A˚
3
min = 0.54 e A˚3
Table 1
Selected geometric parameters (A˚, ).
Cl18—C17 1.740 (3)
Cl28—C27 1.735 (4)
Cl33—C32 1.739 (3)
O10—C9 1.213 (4)
O20—C19 1.227 (3)
N1—C2 1.382 (4)
N1—C6 1.376 (4)
N11—C9 1.357 (4)
N11—C12 1.404 (4)
N21—C19 1.353 (4)
N21—C22 1.410 (5)
C2—N1—C6 124.0 (2)
C9—N11—C12 129.0 (2)
C19—N21—C22 128.8 (3)
N1—C2—C3 119.1 (3)
N1—C2—C8 112.0 (2)
N1—C6—C5 119.5 (3)
N1—C6—C7 112.9 (3)
O10—C9—N11 120.8 (2)
O10—C9—C3 120.2 (3)
N11—C9—C3 119.1 (2)
N11—C12—C17 118.3 (3)
N11—C12—C13 124.2 (3)
Cl18—C17—C12 120.0 (3)
Cl18—C17—C16 118.1 (3)
O20—C19—N21 120.7 (3)
O20—C19—C5 123.5 (3)
N21—C19—C5 115.8 (2)
N21—C22—C23 124.0 (3)
N21—C22—C27 118.5 (3)
Cl28—C27—C22 119.8 (3)
Cl28—C27—C26 118.1 (3)
Cl33—C32—C31 119.8 (2)
Cl33—C32—C34 119.5 (2)
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Figure 1
View of (I), shown with 50% probability displacement ellipsoids.
Figure 2
The crystal packing in (I), viewed down the b axis. Dashed lines indicate
hydrogen bonds.
Table 2
Hydrogen-bond geometry (A˚, ).
D—H  A D—H H  A D  A D—H  A
N1—H1  O20i 0.86 2.05 2.891 (3) 167
N11—H11  Cl18 0.86 2.46 2.943 (3) 116
N21—H21  Cl28 0.86 2.48 2.935 (3) 114
C4—H4  N21 0.98 2.54 2.905 (4) 102
C7—H7C  O20 0.96 2.36 2.838 (4) 110
C8—H8B  O20i 0.96 2.56 3.423 (4) 149
C13—H13  O10 0.93 2.24 2.833 (5) 121
C23—H23  O20 0.93 2.28 2.842 (5) 119
C34—H34  O10ii 0.93 2.49 3.227 (4) 136
Symmetry codes: (i) xþ 12;þy  12;z 12; (ii) xþ 12;y þ 52;z.
H atoms were placed at idealized positions and allowed to ride on
their parent atoms, with C—H distances in the range 0.93–0.98 A˚ and
N—H = 0.86 A˚; Uiso(H) values were set equal to xUeq(carrier atom),
where x = 1.5 for methyl H atoms and 1.2 for all other H atoms.
Data collection: XPRESS (MacScience, 2002); cell refinement:
SCALEPACK (Otwinowski & Minor, 1997); data reduction:
SCALEPACK and DENZO (Otwinowski & Minor, 1997);
program(s) used to solve structure: SHELXS97 (Sheldrick, 1990);
program(s) used to refine structure: SHELXL97 (Sheldrick, 1997);
molecular graphics: PLATON (Spek, 2003) and ORTEPII (Johnson,
1976); software used to prepare material for publication:
SHELXL97.
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